3,499 reports of this reaction
3.4% of all FINASTERIDE reports
#3 most reported adverse reaction
DEPRESSION is the #3 most commonly reported adverse reaction for FINASTERIDE, manufactured by Organon LLC. There are 3,499 FDA adverse event reports linking FINASTERIDE to DEPRESSION. This represents approximately 3.4% of all 103,583 adverse event reports for this drug.
Patients taking FINASTERIDE who experience depression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEPRESSION is moderately reported among FINASTERIDE users, representing a notable but not dominant share of adverse events.
In addition to depression, the following adverse reactions have been reported for FINASTERIDE:
The following drugs have also been linked to depression in FDA adverse event reports:
DEPRESSION has been reported as an adverse event in 3,499 FDA reports for FINASTERIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEPRESSION accounts for approximately 3.4% of all adverse event reports for FINASTERIDE, making it one of the most commonly reported side effect.
If you experience depression while taking FINASTERIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.